Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $714,211 - $1.22 Million
-3,736 Reduced 61.25%
2,364 $769,000
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $341,298 - $457,262
2,120 Added 53.27%
6,100 $1.16 Million
Q3 2023

Nov 15, 2023

BUY
$194.33 - $283.97 $397,793 - $581,286
2,047 Added 105.9%
3,980 $792,000
Q2 2023

Aug 23, 2023

SELL
$223.05 - $302.68 $89,443 - $121,374
-401 Reduced 17.18%
1,933 $551,000
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $409,406 - $508,625
2,334 New
2,334 $500,000
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $770,298 - $1.23 Million
3,946 New
3,946 $1.09 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $458,539 - $848,482
-3,956 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $726,940 - $1.18 Million
-5,681 Reduced 58.95%
3,956 $771,000
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $601,238 - $880,503
3,641 Added 60.72%
9,637 $1.73 Million
Q3 2021

Nov 12, 2021

SELL
$163.99 - $235.57 $176,945 - $254,180
-1,079 Reduced 15.25%
5,996 $1.23 Million
Q2 2021

Aug 06, 2021

SELL
$131.45 - $201.49 $1.37 Million - $2.11 Million
-10,454 Reduced 59.64%
7,075 $1.36 Million
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $185 - $284
-2 Reduced 0.01%
17,529 $2.15 Million
Q4 2020

Feb 12, 2021

SELL
$67.44 - $103.72 $467,156 - $718,468
-6,927 Reduced 28.32%
17,531 $1.77 Million
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $482,457 - $854,645
11,275 Added 85.53%
24,458 $1.82 Million
Q2 2020

Aug 13, 2020

BUY
$27.25 - $47.53 $128,102 - $223,438
4,701 Added 55.42%
13,183 $610,000
Q1 2020

May 11, 2020

BUY
$23.16 - $47.74 $68,808 - $141,835
2,971 Added 53.91%
8,482 $305,000
Q4 2019

Feb 12, 2020

BUY
$29.4 - $44.98 $162,023 - $247,884
5,511 New
5,511 $244,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.